With price action similar to the Amgen reversal, senior mining index GDX, is testing resistance.
As if taking a cue from yesterday’s report on gold heading lower, today we have gold and the miners deciding to head higher.
All is not what it seems however.
The GDX chart above, shows we’re already in up-thrust condition. There has been a sign of supply (selling overwhelming the buying) and now we’re heading up into a test.
Going back to this report on Amgen, it’s a near exact replica of price action; except it’s (apparently) taking place quicker.
Note the bottom of the ‘Sign of Supply’ is a Fibonacci 8-Days from the high posted on April 21st.
That would naturally lend itself to expect testing action to complete on Fibonacci Day 13, which is this coming Friday.
Remember, that as soon as everyone’s got it figured out (Fibonacci time frame) it changes to something else. So, if no one is really paying attention and still in the hyper-inflation bull camp, they’ll look at this action as a bull move; missing the reversal (when or if it comes).
Tests can fail as well. GDX could push through the resistance and negate the up-thrust.
As stated many times before, the gold market’s too crowded with too many rabid bulls.
This may be a good test and reversal set-up but we’ll stick with shorting biotech (not advice, not a recommendation).
By the way … biotech’s doing very well on the short side today … 🙂
The wheels are falling off the ‘speck’ false narrative; tragically so.
The following is taken from the comment section of the video post:
From the guy who filmed :
“Less than 5 minutes from getting God knows what injected inside them the two people to my left starting having seizures. First the gentlemen in the red car was watching in shock as the driver next to him was having a seizure. Little did he know he would have one right after him. I called the medics to help him. They have a procedure where after you get the shot you have to wait in the car for 15 min and if something goes wrong to honk your horn and someone will show up. Well these folks to my left just passed out into seizures with no warning.
You would think it’s just a matter of time before this reaches some kind of tipping point; where enough of the herd realizes all at once, the lie.
The last post has us breaking the rules. Was that the right thing to do?
This morning’s price action has the answer: Yes.
The Project Stimulus table has been updated to include the new (hard) stop level. With LABD currently up a good 5.50%, and looking to move higher, it’s not likely the stop will be hit.
There is one caveat: As of this post, IBB has not printed a new daily low. That leaves the (slight) possibility open for a move higher.
Several attempts have been made to short biotech via LABD (not advice, not a recommendation). It looks like the current attempt is underway.
The 15-minute chart of inverse fund LABD shows how successive moves lower (higher for IBB) have covered less distance.
It’s very early in the session and price action at this moment is fighting it out at LABD 18.00, area.
We’ve maintained our short position (not advice, not a recommendation) but have the sense, if there’s not a reversal at this point, IBB could be working up for new all time highs.
This is the danger point.
Current LABD low for the early session is 17.91 … a good place for a stop.
LABD pushed down to 17.80, early in the session before reversing.
It has just passed 18.28, a new hourly high. AMGN to be covered later, at important inflection point (down).
Short position via LABD maintained (not advice, not a recommendation), hard stop at 17.80
With markets at record prices, Fed announcement tomorrow, no more stimulus (likely), forbearance to end, possibility of the ‘speck’ blowing wide open, one gets the sense this may be an important reversal.
Note: Posts on this site are for education purposes only. They provide one firm’s insight on the markets. Not investment advice. See additional disclaimer here.